Back to Search
Start Over
Baricitinib plus dexamethasone compared to dexamethasone for the treatment of severe COVID-19 pneumonia: A retrospective analysis
- Source :
- Journal of Microbiology, Immunology and Infection, Vol 54, Iss 5, Pp 787-793 (2021)
- Publication Year :
- 2021
- Publisher :
- Elsevier, 2021.
-
Abstract
- Objective: We aimed to analyze clinical outcomes from patients with severe COVID-19 pneumonia that received either baricitinib plus dexamethasone or dexamethasone monotherapy. Methodology: We performed a retrospective comparative study. Data from hospitalized patients with severe COVID-19 pneumonia (saturation
- Subjects :
- COVID-19
SARS-CoV-2
Baricitinib
Dexamethasone
Microbiology
QR1-502
Subjects
Details
- Language :
- English
- ISSN :
- 16841182
- Volume :
- 54
- Issue :
- 5
- Database :
- Directory of Open Access Journals
- Journal :
- Journal of Microbiology, Immunology and Infection
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.2a094957337242a89db882a8d86cf398
- Document Type :
- article
- Full Text :
- https://doi.org/10.1016/j.jmii.2021.05.009